{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:17:01Z","timestamp":1770959821227,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T00:00:00Z","timestamp":1716163200000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.bmcl.2023.129329","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T01:00:01Z","timestamp":1684198801000},"page":"129329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Improved synthesis and anticancer activity of a potent neuronal nitric oxide synthase inhibitor"],"prefix":"10.1016","volume":"90","author":[{"given":"Dhananjayan","family":"Vasu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cory T.","family":"Reidl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9034-1084","authenticated-orcid":false,"given":"Richard B.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2023.129329_b0005","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1200\/JCO.2014.56.6018","article-title":"Five-year survival rates for treatment-na\u00efve patients with advanced melanoma who received ipilimumab plus darcarbazine in a phase III trial","volume":"33","author":"Maio","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bmcl.2023.129329_b0010","series-title":"Risk of Dying from Cancer Continues to Drop at an Accelerated Pace","article-title":"Cancer Facts & Figures","author":"American Cancer Society","year":"2022"},{"key":"10.1016\/j.bmcl.2023.129329_b0015","unstructured":"CancerProgressReport.org [Internet]. Philadelphia: American Association for Cancer Research; \u00a92022 [cited 2022 Nov. 02]. http:\/\/www.cancerprogressreport.org\/."},{"key":"10.1016\/j.bmcl.2023.129329_b0020","first-page":"495","article-title":"Global burden of cutaneous melanoma in 2020 and projections to 2040","volume":"158","author":"Arnold","year":"2022","journal-title":"J Am Med Assoc Dermatol"},{"key":"10.1016\/j.bmcl.2023.129329_b0025","first-page":"3751","article-title":"Nitric oxide initiates progression of human melanoma via a feedback loop mediated by apurinic\/apyrimidinic endonuclease-1\/redox factor-1, which is inhibited by resveratrol","volume":"12","author":"Yang","year":"2008","journal-title":"Mol CancerTher"},{"key":"10.1016\/j.bmcl.2023.129329_b0030","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12967-022-03403-w","article-title":"Inhibition of NOS1 promotes the interferon response of melanoma cells","volume":"20","author":"Chen","year":"2022","journal-title":"J Transl Med"},{"key":"10.1016\/j.bmcl.2023.129329_b0035","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1172\/JCI69611","article-title":"Melanoma NOS1 expression promotes dysfunctional IFN signaling","volume":"124","author":"Liu","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bmcl.2023.129329_b0040","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1038\/s41598-022-05394-6","article-title":"Inhibition of interferon-gamma-stimulated melanoma progression by targeting neuronal nitric oxide synthase (nNOS)","volume":"12","author":"Tong","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmcl.2023.129329_b0045","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3390\/pharmaceutics14051036","article-title":"A small peptide increases drug delivery in human melanoma cells","volume":"14","author":"Tong","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bmcl.2023.129329_b0050","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1089\/ars.2012.4563","article-title":"Targeting nitric oxide signaling with nNOS inhibitors as a novel strategy for the therapy and prevention of human melanoma","volume":"19","author":"Yang","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.bmcl.2023.129329_b0055","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1021\/acs.jmedchem.7b00259","article-title":"Nitrile in the hole: discovery of a small auxiliary pocket in neuronal nitric oxide synthase leading to the development of potent and selective 2-aminoquinoline inhibitors","volume":"60","author":"Cinelli","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2023.129329_b0060","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1021\/jo070189y","article-title":"A general and efficient 2-amination of pyridines and quinolines","volume":"72","author":"Yin","year":"2007","journal-title":"J Organic Chem"},{"key":"10.1016\/j.bmcl.2023.129329_b0065","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1016\/j.tetlet.2009.06.077","article-title":"7-Chloroquinoline: A versatile intermediate for the synthesis of 7-substituted quinolines","volume":"50","author":"Hirner","year":"2009","journal-title":"TetrahedronLett"},{"key":"10.1016\/j.bmcl.2023.129329_b0070","first-page":"934","article-title":"On the Knorr synthesis of 6-bromo-4-methylquinolin-2(1H)-one","volume":"6","author":"Wlodarczyk","year":"2011","journal-title":"Synthesis"},{"key":"10.1016\/j.bmcl.2023.129329_b0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/jlac.18862360105","article-title":"Synthetische Vesuche mit dem Acetessigester","volume":"236","author":"Knorr","year":"1886","journal-title":"Justus Liebigs Ann Chem"},{"key":"10.1016\/j.bmcl.2023.129329_b0080","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1021\/jm200544q","article-title":"From fragment screening to in vivo efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1)","volume":"54","author":"Cheng","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2023.129329_b0085","unstructured":"Konradi AW, Lin T. Bicylic Compounds. From PCT Int. Appl., 2020097389."},{"key":"10.1016\/j.bmcl.2023.129329_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116878","article-title":"2-Aminopyridines with a shortened amino sidechain as potent, selective, and highly permeable human neuronal nitric oxide synthase inhibitors","volume":"69","author":"Vasu","year":"2022","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2023.129329_b0095","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1089\/ars.2016.6820","article-title":"NOS expression and NO function in glioma and implications for patient therapies","volume":"26","author":"Tran","year":"2017","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.bmcl.2023.129329_b0100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2174\/0929867327666200130104757","article-title":"Protective role of natural products in glioblastoma multiforme: a focus on nitric oxide pathway","volume":"28","author":"Afshari","year":"2021","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmcl.2023.129329_b0105","first-page":"273","article-title":"Nitric oxide synthase expression and enzymatic activity in human brain tumors","volume":"22","author":"Broholm","year":"2003","journal-title":"Clin Neuropathol"},{"issue":"3","key":"10.1016\/j.bmcl.2023.129329_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120435","article-title":"The impact of tumor nitric oxide production on VEGFA Expression and tumor growth in a zebrafish rat glioma xenograft model","volume":"10","author":"Yousfi","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.bmcl.2023.129329_b0115","first-page":"4891","article-title":"Function of neuronal nitric oxide synthase enzyme in temozolomide-induced damage of astrocytic tumor cells","volume":"15","author":"Resende","year":"2018","journal-title":"Oncol Lett"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2300207X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2300207X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:48:17Z","timestamp":1760773697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X2300207X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":23,"alternative-id":["S0960894X2300207X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2023.129329","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved synthesis and anticancer activity of a potent neuronal nitric oxide synthase inhibitor","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2023.129329","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"129329"}}